Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$93.82
+1.45%
Mkt Cap $4.59B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $142.50M | $148.93M | +4.51% | $0.02 | -$0.11 | -650.00% | — | — |
| Q4 2025 Nov 4, 2025 | $140.88M | $133.01M | -5.59% | -$0.10 | $0.05 | +150.00% | — | — |
| Q3 2025 Aug 6, 2025 | $130.11M | $127.78M | -1.79% | -$0.31 | -$0.12 | +61.29% | — | — |
| Q2 2025 May 7, 2025 | $98.40M | $111.58M | +13.40% | -$0.39 | -$0.30 | +23.08% | — | — |
| Q1 2025 Feb 26, 2025 | $96.64M | $99.41M | +2.87% | -$0.27 | -$0.49 | -81.48% | — | — |
| Q4 2024 Nov 12, 2024 | $95.44M | $90.38M | -5.31% | -$0.45 | -$0.30 | +33.33% | — | — |
| Q3 2024 Aug 7, 2024 | $75.25M | $77.88M | +3.49% | -$0.48 | -$0.52 | -8.33% | — | — |
| Q2 2024 May 8, 2024 | $70.17M | $69.22M | -1.35% | -$0.40 | -$0.54 | -35.00% | — | — |
| Q1 2024 Feb 28, 2024 | $67.76M | $69.55M | +2.65% | -$0.34 | -$0.66 | -94.12% | — | — |
| Q4 2023 Nov 2, 2023 | $68.27M | $47.73M | -30.09% | -$0.64 | -$0.57 | +10.94% | — | — |
| Q3 2023 Aug 3, 2023 | $32.47M | $37.50M | +15.48% | -$0.81 | -$0.92 | -13.58% | — | — |
| Q2 2023 May 4, 2023 | $28.69M | $31.60M | +10.14% | -$0.96 | -$0.80 | +16.67% | — | — |
| Q1 2023 Mar 8, 2023 | $24.57M | $27.91M | +13.58% | -$0.98 | -$0.99 | -1.02% | — | — |
| Q4 2022 Nov 9, 2022 | $20.81M | $18.78M | -9.75% | -$1.05 | -$1.02 | +2.86% | — | — |
| Q3 2022 Aug 4, 2022 | $15.42M | $17.48M | +13.41% | -$1.05 | -$0.84 | +20.00% | — | — |
| Q2 2022 May 5, 2022 | $8.46M | $12.89M | +52.33% | -$1.39 | -$1.17 | +15.83% | — | — |
| Q1 2022 Mar 9, 2022 | $62.67M | $3.14M | -94.99% | -$0.61 | -$0.92 | -50.82% | — | — |
| Q4 2021 Nov 15, 2021 | $830.00K | $5.00M | +502.41% | -$1.63 | -$1.55 | +4.91% | — | — |
| Q3 2021 Aug 5, 2021 | $14.50M | $11.00M | -24.14% | -$0.41 | -$1.45 | -253.66% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.67 | -$1.68 | -150.75% | — | — |